logo
[breadcrumb_custom]

Tag: BCLI Stock

CROX
Finance

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -78.36% away from its 52-week high, while its distance from the 52-week low is 444.78%. The stock’s price range over this period has fluctuated between $0.13 and $3.37. The company, operating within the financial sector, had a trading volume of approximately 1.04 million for the day, which was noticeably higher than the average daily share volume of 0.96 million over the last 3 months. In terms of market performance,

OPEN Stock
Finance

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: Exploring a Year of Highs, Lows, and Trading Volume

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -78.62% away from its 52-week high, while its distance from the 52-week low is 452.16%. The stock’s price range over this period has fluctuated between $0.13 and $3.46. The company, operating within the financial sector, had a trading volume of approximately 1.44 million for the day, which was noticeably higher than the average daily share volume of 0.97 million over the last 3 months. Brainstorm Cell Therapeutics, Inc. experienced

Stock

The Psychology of Brainstorm Cell Therapeutics, Inc. Inc. (BCLI) Price Performance: Understanding Market Sentiment

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 119.85%. However, over the past six months, we’ve seen a weaker performance of 40.33%. The price of BCLI fallen by 65.34% over the last 30 days. And in the last five days, it has surged by 18.38%. In terms of market performance, Brainstorm Cell Therapeutics, Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $3.46 on 03/31/23, while the lowest value

Stock

Brainstorm Cell Therapeutics, Inc.’s: Contrasting Stock Performances in a Volatile Market

The market performance of Brainstorm Cell Therapeutics, Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.46 on 03/31/23, with the lowest value for the same timeframe being $0.13, recorded on 10/31/23. 52-week price history of BCLI Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -81.07% away from its 52-week high, while its distance from the 52-week low is 388.81%. The stock’s price range for this

Industry

BCLI’s 52-Week Rollercoaster: From $0.13 to $3.46 – What’s Next for Investors?

Brainstorm Cell Therapeutics, Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.46 on 03/31/23, while the lowest price during the same period was $0.13 on 10/31/23. 52-week price history of BCLI Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -83.53% away from its 52-week high, while its distance from the 52-week low is 325.37%. The stock’s price range during this period has fluctuated

Stock

Brainstorm Cell Therapeutics, Inc.: Navigating a Turbulent Year, Up -89.72% from 52-Week Low

The market performance of Brainstorm Cell Therapeutics, Inc.’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $3.46 on 03/31/23, while the lowest value for the same duration was $0.13 on 10/31/23. 52-week price history of BCLI Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Brainstorm Cell Therapeutics, Inc.’s current trading price is -89.72% away from its 52-week high, while its distance from the 52-week low is 165.45%. The stock’s price range during this period has spanned from $0.13 to

SLGG
Stock

Brainstorm Cell Therapeutics, Inc. (BCLI) Stock: From Low to High in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -90.45% away from its 52-week high, while its distance from the 52-week low is 146.72%. The stock’s price range for this period has been between $0.13 and $3.46 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.68 million for the day, a number notably lower than the average daily volume of 1.4 million over the last three months. The market performance of Brainstorm Cell

Stock

Brainstorm Cell Therapeutics, Inc. (BCLI Stock: A Sea of Opportunity

Brainstorm Cell Therapeutics, Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.46 on 03/31/23, while the lowest price for the same period was registered at $0.13 on 10/31/23. 52-week price history of BCLI Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -89.95% away from its 52-week high, while its distance from the 52-week low is 159.63%. The stock’s price range during the 52-week period has remained